Exhibit 23.1
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
We hereby consent to the use in this Registration Statement on Form SB-2 of our
report, dated September 8, 2000, which includes an emphasis paragraph relating
to an uncertainty as to the Company's ability to continue as a going concern on
the restated consolidated financial statements of Meditech Pharmaceuticals, Inc.
and subsidiary. We also consent to the reference to our Firm under the captions
"Experts" in the Prospectus.
SINGER LEWAK GREENBAUM & GOLDSTEIN LLP
Los Angeles, California
September 18, 2000
